January 9th 2025
This study builds on previous animal research that found the lipid emulsion made from Ahiflower was associated with significantly lower inflammation, improved insulin sensitivity, and improved gut microbiota, compared to that of soybean oil or fish oil.
Aker BioMarine signs license and supply agreement for Lysoveta with Trofi Nutritionals
September 2nd 2022As part of the agreement, Aker BioMarine will license and supply Lysoveta to Trofi, who will invest in clinical trials with the aim to develop and commercialize certain medical foods within the fields.
Peer-reviewed article highlights methodology of GOED’s new clinical study database
July 8th 2022The paper provides transparency into how the database collects and processes the research it compiles, insights into the design of its graphical user interface, as well as the database’s strengths and limitations.
Pentadecanoic acid may offer more benefits than EPA, says newly published study
May 26th 2022A new study shows that an odd-chain saturated fat, called Pentadecanoic acid (C:15:0), may be healthier, safer, and more effective for supporting cellular health than the leading omega-3 fatty acid, eicosapentaenoic acid (EPA).
GC Rieber VivoMega to make significant investment in facility expansion
May 6th 2022GC Rieber VivoMega has announced a five-year $75 million investment plan to build a new facility at its manufacturing campus. The new facility will enable the company to more than double the output of its high-end triglyceride form of omega-3s EPA and DHA.